Abbott Adds MRI-Compatibility to Ellipse Defibrillator

October 4, 2017

The FDA approved conditional labeling of magnetic resonance for Abbott’s Ellipse implantable cardioverter defibrillator. The addition allows patients with the implants to undergo MRI scans.

Ellipse monitors heart rhythms and can deliver a shock to a patient’s heart.

The data captured by the device and wirelessly transferred allows for remote monitoring to help the patient’s care provider determine whether intervention is needed.

View today's stories